| Inorganic Polyphosphate in Escherichia coli: the Phosphate Regulon and the Stringent Response NN Rao, S Liu, A Kornberg Journal of bacteriology 180 (8), 2186-2193, 1998 | 279 | 1998 |
| Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Van de Water, A Ansari, T Prindiville, RL Coppel, N Ricalton, BL Kotzin, ... Journal of Experimental Medicine 181 (2), 723-733, 1995 | 164 | 1995 |
| rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis W Shen, S Liu, L Ou Frontiers in immunology 13, 1001263, 2022 | 101 | 2022 |
| Binding of the pyruvate dehydrogenase kinase to recombinant constructs containing the inner lipoyl domain of the dihydrolipoyl acetyltransferase component S Liu, JC Baker, TE Roche Journal of Biological Chemistry 270 (2), 793-800, 1995 | 93 | 1995 |
| Activated function of the pyruvate dehydrogenase phosphatase through Ca2+-facilitated binding to the inner lipoyl domain of the dihydrolipoyl acetyltransferase G Chen, L Wang, S Liu, C Chuang, TE Roche Journal of Biological Chemistry 271 (45), 28064-28070, 1996 | 68 | 1996 |
| Development and qualification of a novel virus removal filter for cell culture applications S Liu, M Carroll, R Iverson, C Valera, J Vennari, K Turco, R Piper, R Kiss, ... Biotechnology progress 16 (3), 425-434, 2000 | 50 | 2000 |
| Retrospective evaluation of low-pH viral inactivation and viral filtration data from a multiple company collaboration J Mattila, M Clark, S Liu, J Pieracci, TR Gervais, E Wilson, O Galperina, ... PDA Journal of Pharmaceutical Science and Technology 70 (3), 293-299, 2016 | 44 | 2016 |
| Detection of minute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of Mammalian cell substrate derived biotherapeutics D Zhan, MR Roy, C Valera, J Cardenas, JC Vennari, JW Chen, S Liu Biologicals 30 (4), 259-270, 2002 | 43 | 2002 |
| Recombinant expression and evaluation of the lipoyl domains of the dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex SJ Liu, JC Baker, PC Andrews, TE Roche Archives of biochemistry and biophysics 316 (2), 926-940, 1995 | 41 | 1995 |
| Application of multivirus spike approach for viral clearance evaluation CR Valera, JW Chen, Y Xu Biotechnology and bioengineering 84 (6), 714-722, 2003 | 31 | 2003 |
| Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates S Liu, X Gong, X Yan, T Peng, JC Baker, L Li, PM Robben, S Ravindran, ... Archives of Biochemistry and Biophysics 386 (2), 123-135, 2001 | 31 | 2001 |
| Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells S Liu, J Li, S Peraramelli, N Luo, A Chen, M Dai, F Liu, Y Yu, RD Leib, Y Li, ... Molecular Therapy 32 (1), 74-83, 2024 | 18 | 2024 |
| Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis W Shen, S Liu, L Ou Frontiers in Immunology 13, 1104646, 2023 | 8 | 2023 |
| Macular retina-targeting AAV capsid identified through multi-species screening in mice, rabbits, pigs, and monkeys SS Liu, H Chen, S Peraramelli, N Luo, X Chen, J Li, X Gong, E Santillan, ... Investigative Ophthalmology & Visual Science 65 (7), 5323-5323, 2024 | 2 | 2024 |
| Proceedings of the 2017 Viral Clearance Symposium, Session 1.2: Upstream Mitigation, Part 2—Virus Barrier Filter and HTST D Chen, G Bolton PDA Journal of Pharmaceutical Science and Technology 72 (5), 462-469, 2018 | 1 | 2018 |
| Compositions and methods for transgene expression S Liu US Patent App. 18/584,397, 2024 | | 2024 |
| Novel AAV2 capsid expressing Aflibercept shows efficacy and sustainability in rabbit DL-AAA model at picogram level S Peraramelli, E Santillan, J Li, N Luo, X Chen, K Lin, D Huynh, S Li, L Ou, ... Investigative Ophthalmology & Visual Science 65 (7), 6163-6163, 2024 | | 2024 |
| Comprehensive comparison of rAAV vectors derived from Sf9 and HEK293 cells for ocular genetherapy SS Liu Investigative Ophthalmology & Visual Science 65 (7), 5600-5600, 2024 | | 2024 |
| Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection S Liu, H Chen, X Chen, N Luo, S Peraramelli, X Gong, MJ Zhang, L Ou Frontiers in Immunology 15, 1365803, 2024 | | 2024 |
| Compositions and methods for ocular transgene expression S Liu, H Chen US Patent App. 18/482,767, 2024 | | 2024 |